Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

The microbiome in lung cancer tissue and recurrence-free survival.

Peters BA, Hayes RB, Goparaju C, Reid C, Pass HI, Ahn J.

Cancer Epidemiol Biomarkers Prev. 2019 Feb 7. pii: cebp.0966.2018. doi: 10.1158/1055-9965.EPI-18-0966. [Epub ahead of print]

PMID:
30733306
2.

A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations.

Pastorino S, Yoshikawa Y, Pass HI, Emi M, Nasu M, Pagano I, Takinishi Y, Yamamoto R, Minaai M, Hashimoto-Tamaoki T, Ohmuraya M, Goto K, Goparaju C, Sarin KY, Tanji M, Bononi A, Napolitano A, Gaudino G, Hesdorffer M, Yang H, Carbone M.

J Clin Oncol. 2018 Oct 30:JCO2018790352. doi: 10.1200/JCO.2018.79.0352. [Epub ahead of print]

PMID:
30376426
3.

Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.

Ooki A, Dinalankara W, Marchionni L, Tsay JJ, Goparaju C, Maleki Z, Rom WN, Pass HI, Hoque MO.

Oncogene. 2018 Nov;37(45):5967-5981. doi: 10.1038/s41388-018-0373-2. Epub 2018 Jul 6.

4.

Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications.

Barash U, Lapidot M, Zohar Y, Loomis C, Moreira A, Feld S, Goparaju C, Yang H, Hammond E, Zhang G, Li JP, Ilan N, Nagler A, Pass HI, Vlodavsky I.

J Natl Cancer Inst. 2018 Oct 1;110(10):1102-1114. doi: 10.1093/jnci/djy032.

PMID:
29579286
5.

Summarizing performance for genome scale measurement of miRNA: reference samples and metrics.

Pine PS, Lund SP, Parsons JR, Vang LK, Mahabal AA, Cinquini L, Kelly SC, Kincaid H, Crichton DJ, Spira A, Liu G, Gower AC, Pass HI, Goparaju C, Dubinett SM, Krysan K, Stass SA, Kukuruga D, Van Keuren-Jensen K, Courtright-Lim A, Thompson KL, Rosenzweig BA, Sorbara L, Srivastava S, Salit ML.

BMC Genomics. 2018 Mar 6;19(1):180. doi: 10.1186/s12864-018-4496-1.

6.

Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis.

Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, Karakousi TR, Ellis DC, Bhutkar A, Sánchez-Rivera FJ, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, Thomas CJ, Goparaju C, Davies A, Dolgalev I, Heguy A, Allaj V, Poirier JT, Moreira AL, Rudin CM, Pass HI, Vander Heiden MG, Jacks T, Papagiannakopoulos T.

Nat Med. 2017 Nov;23(11):1362-1368. doi: 10.1038/nm.4407. Epub 2017 Oct 2.

7.

A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.

Ooki A, Maleki Z, Tsay JJ, Goparaju C, Brait M, Turaga N, Nam HS, Rom WN, Pass HI, Sidransky D, Guerrero-Preston R, Hoque MO.

Clin Cancer Res. 2017 Nov 15;23(22):7141-7152. doi: 10.1158/1078-0432.CCR-17-1222. Epub 2017 Aug 29.

8.

High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma.

Yoshikawa Y, Emi M, Hashimoto-Tamaoki T, Ohmuraya M, Sato A, Tsujimura T, Hasegawa S, Nakano T, Nasu M, Pastorino S, Szymiczek A, Bononi A, Tanji M, Pagano I, Gaudino G, Napolitano A, Goparaju C, Pass HI, Yang H, Carbone M.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13432-13437. Epub 2016 Nov 9.

9.

Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin.

Pass HI, Lavilla C, Canino C, Goparaju C, Preiss J, Noreen S, Blandino G, Cioce M.

Oncotarget. 2016 Aug 30;7(35):56408-56421. doi: 10.18632/oncotarget.10895.

10.

Extracellular mRNA Detected by Tethered Lipoplex Nanoparticle Biochip for Lung Adenocarcinoma Detection.

Lee LJ, Yang Z, Rahman M, Ma J, Kwak KJ, McElroy J, Shilo K, Goparaju C, Yu L, Rom W, Kim TK, Wu X, He Y, Wang K, Pass HI, Nana-Sinkam SP.

Am J Respir Crit Care Med. 2016 Jun 15;193(12):1431-3. doi: 10.1164/rccm.201511-2129LE. No abstract available.

11.

Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.

Pass HI, Goparaju C, Espin-Garcia O, Donington J, Carbone M, Patel D, Chen Z, Feld R, Cho J, Gadgeel S, Wozniak A, Chachoua A, Leighl N, Tsao MS, de Perrot M, Xu W, Liu G.

J Thorac Oncol. 2016 Jun;11(6):900-9. doi: 10.1016/j.jtho.2016.02.006. Epub 2016 Feb 21.

12.

HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.

Napolitano A, Antoine DJ, Pellegrini L, Baumann F, Pagano I, Pastorino S, Goparaju CM, Prokrym K, Canino C, Pass HI, Carbone M, Yang H.

Clin Cancer Res. 2016 Jun 15;22(12):3087-96. doi: 10.1158/1078-0432.CCR-15-1130. Epub 2016 Jan 5.

13.

Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.

Guo G, Chmielecki J, Goparaju C, Heguy A, Dolgalev I, Carbone M, Seepo S, Meyerson M, Pass HI.

Cancer Res. 2015 Jan 15;75(2):264-9. doi: 10.1158/0008-5472.CAN-14-1008. Epub 2014 Dec 8.

14.

Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation.

Cioce M, Canino C, Goparaju C, Yang H, Carbone M, Pass HI.

Cell Death Dis. 2014 Apr 10;5:e1167. doi: 10.1038/cddis.2014.136.

15.

Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior.

Goparaju C, Donington JS, Hsu T, Harrington R, Hirsch N, Pass HI.

J Thorac Oncol. 2013 Sep;8(9):1203-11. doi: 10.1097/JTO.0b013e31829ceb6a. Erratum in: J Thorac Oncol. 2013 Dec,8(12):1586.

16.

Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting.

Mathur A, Blais S, Goparaju CM, Neubert T, Pass H, Levon K.

PLoS One. 2013;8(3):e57681. doi: 10.1371/journal.pone.0057681. Epub 2013 Mar 13.

17.

Fibulin-3 as a biomarker for pleural mesothelioma.

Pass HI, Goparaju C.

N Engl J Med. 2013 Jan 10;368(2):190. doi: 10.1056/NEJMc1213514. No abstract available.

18.

Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool.

Ostroff RM, Mehan MR, Stewart A, Ayers D, Brody EN, Williams SA, Levin S, Black B, Harbut M, Carbone M, Goparaju C, Pass HI.

PLoS One. 2012;7(10):e46091. doi: 10.1371/journal.pone.0046091. Epub 2012 Oct 3.

19.

Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.

Pass HI, Levin SM, Harbut MR, Melamed J, Chiriboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick L, Goodman GE, Thornquist MD, Liu G, de Perrot M, Tsao MS, Goparaju C.

N Engl J Med. 2012 Oct 11;367(15):1417-27. doi: 10.1056/NEJMoa1115050. Erratum in: N Engl J Med. 2012 Nov;367(18):1768.

20.

Onconase mediated NFKβ downregulation in malignant pleural mesothelioma.

Goparaju CM, Blasberg JD, Volinia S, Palatini J, Ivanov S, Donington JS, Croce C, Carbone M, Yang H, Pass HI.

Oncogene. 2011 Jun 16;30(24):2767-77. doi: 10.1038/onc.2010.643. Epub 2011 Feb 14.

21.

Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.

Goparaju CM, Pass HI, Blasberg JD, Hirsch N, Donington JS.

J Thorac Oncol. 2010 Oct;5(10):1516-23. doi: 10.1097/JTO.0b013e3181eba6bd.

22.

Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.

Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, Bianchi ME, Carbone M.

Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12611-6. doi: 10.1073/pnas.1006542107. Epub 2010 Jun 28.

23.

Pro-tumorigenic effects of miR-31 loss in mesothelioma.

Ivanov SV, Goparaju CM, Lopez P, Zavadil J, Toren-Haritan G, Rosenwald S, Hoshen M, Chajut A, Cohen D, Pass HI.

J Biol Chem. 2010 Jul 23;285(30):22809-17. doi: 10.1074/jbc.M110.100354. Epub 2010 May 12.

24.

hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.

Pass HI, Goparaju C, Ivanov S, Donington J, Carbone M, Hoshen M, Cohen D, Chajut A, Rosenwald S, Dan H, Benjamin S, Aharonov R.

Cancer Res. 2010 Mar 1;70(5):1916-24. doi: 10.1158/0008-5472.CAN-09-3993. Epub 2010 Feb 16.

25.

Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.

Blasberg JD, Pass HI, Goparaju CM, Flores RM, Lee S, Donington JS.

J Clin Oncol. 2010 Feb 20;28(6):936-41. doi: 10.1200/JCO.2009.25.5711. Epub 2010 Jan 19.

26.

Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity.

Blasberg JD, Goparaju CM, Pass HI, Donington JS.

J Thorac Cardiovasc Surg. 2010 Jun;139(6):1587-93. doi: 10.1016/j.jtcvs.2009.08.016. Epub 2009 Oct 9.

27.

Protumorigenic role of HAPLN1 and its IgV domain in malignant pleural mesothelioma.

Ivanova AV, Goparaju CM, Ivanov SV, Nonaka D, Cruz C, Beck A, Lonardo F, Wali A, Pass HI.

Clin Cancer Res. 2009 Apr 15;15(8):2602-11. doi: 10.1158/1078-0432.CCR-08-2755. Epub 2009 Apr 7.

28.

Tumorigenic properties of alternative osteopontin isoforms in mesothelioma.

Ivanov SV, Ivanova AV, Goparaju CM, Chen Y, Beck A, Pass HI.

Biochem Biophys Res Commun. 2009 May 8;382(3):514-8. doi: 10.1016/j.bbrc.2009.03.042. Epub 2009 Mar 13.

PMID:
19285954
29.

Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression.

Narayan G, Goparaju C, Arias-Pulido H, Kaufmann AM, Schneider A, Dürst M, Mansukhani M, Pothuri B, Murty VV.

Mol Cancer. 2006 May 15;5:16.

30.

Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities.

Lu IL, Huang CF, Peng YH, Lin YT, Hsieh HP, Chen CT, Lien TW, Lee HJ, Mahindroo N, Prakash E, Yueh A, Chen HY, Goparaju CM, Chen X, Liao CC, Chao YS, Hsu JT, Wu SY.

J Med Chem. 2006 May 4;49(9):2703-12.

PMID:
16640330
31.

Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activities.

Mahindroo N, Huang CF, Peng YH, Wang CC, Liao CC, Lien TW, Chittimalla SK, Huang WJ, Chai CH, Prakash E, Chen CP, Hsu TA, Peng CH, Lu IL, Lee LH, Chang YW, Chen WC, Chou YC, Chen CT, Goparaju CM, Chen YS, Lan SJ, Yu MC, Chen X, Chao YS, Wu SY, Hsieh HP.

J Med Chem. 2005 Dec 29;48(26):8194-208.

PMID:
16366601
32.

Comet assay with nuclear extract incubation.

Wang AS, Ramanathan B, Chien YH, Goparaju CM, Jan KY.

Anal Biochem. 2005 Feb 1;337(1):70-5.

PMID:
15649377
33.

Purification and characterization of human prolyl dipeptidase DPP8 in Sf9 insect cells.

Chen YS, Chien CH, Goparaju CM, Hsu JT, Liang PH, Chen X.

Protein Expr Purif. 2004 May;35(1):142-6.

PMID:
15039077
34.

A simple method for generating full length cDNA from low abundance partial genomic clones.

Wang Y, Fugaro JM, Siddiq F, Goparaju CM, Lonardo F, Wali A, Lechner JF, Pass HI.

BMC Mol Biol. 2000;1:2. Epub 2000 Nov 16.

Supplemental Content

Loading ...
Support Center